Candel Therapeutics (CADL) had the highest return between January 1, 2024 and May 31, 2024 by a small-cap US stock, returning 497.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
Candel Therapeutics (CADL) | 1/1/2024 - 5/31/2024 | 497.32% |
Janux Therapeutics (JANX) | 1/1/2024 - 5/31/2024 | 400.94% |
Root (ROOT) | 1/1/2024 - 5/31/2024 | 387.91% |
Rezolute (RZLT) | 1/1/2024 - 5/31/2024 | 315.46% |
Entera Bio (ENTX) | 1/1/2024 - 5/31/2024 | 257.09% |
Perspective Therapeutics (CATX) | 1/1/2024 - 5/31/2024 | 244.91% |
Novavax (NVAX) | 1/1/2024 - 5/31/2024 | 211.83% |
Real Brokerage (REAX) | 1/1/2024 - 5/31/2024 | 201.89% |
Ocugen (OCGN) | 1/1/2024 - 5/31/2024 | 195.22% |
Sonida Senior Living (SNDA) | 1/1/2024 - 5/31/2024 | 189.12% |
Climb Bio (CLYM) | 1/1/2024 - 5/31/2024 | 185.56% |
Stoke Therapeutics (STOK) | 1/1/2024 - 5/31/2024 | 183.33% |
ASP Isotopes Inc Common Stock (ASPI) | 1/1/2024 - 5/31/2024 | 182.32% |
Alliance Entertainment Holding Corporation Class A Common Stock (AENT) | 1/1/2024 - 5/31/2024 | 180% |
Sweetgreen (SG) | 1/1/2024 - 5/31/2024 | 177.53% |
Vital Farms (VITL) | 1/1/2024 - 5/31/2024 | 164.24% |
Codere Online US (CDRO) | 1/1/2024 - 5/31/2024 | 158.62% |
Emergent Biosolutions (EBS) | 1/1/2024 - 5/31/2024 | 142.55% |
Q32 Bio (QTTB) | 1/1/2024 - 5/31/2024 | 140.93% |
GH Research (GHRS) | 1/1/2024 - 5/31/2024 | 140.03% |
Benitec Biopharma Ltd ADR (BNTC) | 1/1/2024 - 5/31/2024 | 138.32% |
Cullinan Oncology LLC (CGEM) | 1/1/2024 - 5/31/2024 | 133.13% |
Orion (ORN) | 1/1/2024 - 5/31/2024 | 122.27% |
FTAI Infrastructure (FIP) | 1/1/2024 - 5/31/2024 | 121.68% |
TheRealReal (REAL) | 1/1/2024 - 5/31/2024 | 117.68% |
Small-cap stocks are treated as having a market cap between $300M and $2B.